Pro-inflammatory cytokines and depression in a familial cancer registry

Psycho-Oncology

Volumn 16, Issue 5, 2007, Pages 499-501

  O'Connor, Mary Frances ^a   Irwin, Michael R ^a   Seldon, Joyce ^a   Kwan, Lorna ^a   Ganz, Patricia A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caner; Cytokines; Depression; High risk; Interleukin 6; Oncology

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; SOLUBLE INTERCELLULAR ADHESION MOLECULE; SOLUBLE INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER; CANCER REGISTRY; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; FAMILIAL CANCER; FEMALE; HUMAN; INFLAMMATION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ADULT; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CYTOKINES; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REGISTRIES; SICK ROLE;

EID: 34249655028     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1108     Document Type: Article

References (20)

1. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27(1):24-31.
2. Capuron L, Ravaud A, Gualde N et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 2001; 26(8):797-808.
3. Schaefer M, Horn M, Schmidt F et al. Correlation between sicam-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-α. Brain, Behav Immun 2004;18(6):555-562.
4. Lesperance F, Frasure-Smith N, Theroux P et al. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and c-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161(2): 271-277.
5. Penninx BWJH, Kritchevsky SB, Yaffe K et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 2003;54(5):566.
6. Pike JL, Irwin MR. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav Immun 2006; 20(2):169-174.
7. Trzonkowski P, Mysliwska J, Godlewska B et al. Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain, Behav Immun 2004;18(2):135.
8. Glaser R, Robles TF, Sheridan J et al. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 2003;60(10): 1009-1014.
9. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002; 25(3):154.
10. Reichenberg A, Yirmiya R, Schuld A et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58(5):445-452.
11. Musselman DL, Miller AH, Porter MR et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001; 158(8):1252-1257.
12. Rich T, Innominato PF, Boerner J et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005;11(5):1757-1764.
13. Pasacreta JV. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest 2003;21:588-623.
14. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 1995;52:89-99.
15. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1977; 1:385-401.
16. Ware JE, Sherbourne CD. The mos 36-item short-form health survey (sf-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
17. Aziz N, Nishanian P, Mitsuyasu R et al. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999;6(1):89-95.
18. Lutgendorf SK, Garand L, Buckwalter KC et al. Life stress, mood distrubance, and elevated interleukin-6 in healthy older women. J Gerontol. Ser A, Biol Sci Med Sci 1999;54:M434-M439.
19. Lopez-Garcia E, Schulze MB, Fung TT et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004;80(4): 1029-1035.
20. Pai JK, Pischon T, Ma J et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351(25):2599-2610.